BriaCell Therapeutics Corp. (BCTX)
NASDAQ: BCTX · Real-Time Price · USD
8.09
+0.54 (7.15%)
At close: Dec 24, 2025, 1:00 PM EST
8.33
+0.24 (2.92%)
After-hours: Dec 24, 2025, 4:55 PM EST
BriaCell Therapeutics Market Cap
BriaCell Therapeutics has a market cap or net worth of $15.48 million as of December 24, 2025. Its market cap has decreased by -64.08% in one year.
Market Cap
15.48M
Enterprise Value
4.41M
1-Year Change
-64.08%
Ranking
Category
Stock Price
$8.09
Market Cap Chart
Since February 24, 2021, BriaCell Therapeutics's market cap has decreased from $26.00M to $15.48M, a decrease of -40.46%. That is a compound annual growth rate of -10.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 24, 2025 | 15.20M | -39.20% |
| Dec 31, 2024 | 25.00M | -73.26% |
| Dec 29, 2023 | 93.50M | 37.91% |
| Dec 30, 2022 | 67.80M | -46.74% |
| Dec 31, 2021 | 127.30M | 389.62% |
| Feb 24, 2021 | 26.00M | - |
View and export this data all the way back to 2021. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 959.53B |
| Johnson & Johnson | 495.78B |
| AbbVie | 404.36B |
| UnitedHealth Group | 294.22B |
| AstraZeneca | 287.19B |
| Novartis AG | 267.64B |
| Merck & Co. | 260.71B |
| Novo Nordisk | 232.28B |